Prostate drug trial hope

A NEW prostate cancer drug cuts the risk of early death by a third, a study has found.

Apalutamide also stopped the cancer progressing outside the prostate for 40.5 months. The drug, a hormone therapy in the form of a daily pill, could soon become the standard medication for aggressive prostate cancer.

It was given to men who had stopped responding to other drugs and the University of California trial involved 1,200 men in 23 countries. About 11,800 UK men are killed by the disease a year.